Form 4 for RMD ResMed|
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-22 · accession 0001127602-22-026349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-23 | 2022-11-22 | RMD | Leong Justin | Pres, Asia Latin America | M - OptEx | $57.76 | +15.0K | 63.6K | +31% | +$866.4K |
| D | 2022-11-23 | 2022-11-23 | RMD | Leong Justin | Pres, Asia Latin America | A - Grant | $0.00 | +6,924 | 66.7K | +12% | $0 |
| D | 2022-11-23 | 2022-11-22 | RMD | Leong Justin | Pres, Asia Latin America | S - Sale+OE | $229.50 | -3,777 | 59.8K | -6% | -$866.8K |
| D | 2022-11-23 | 2022-11-22 | RMD | Leong Justin | Pres, Asia Latin America | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2022-11-22 | M | A | 15,000 | $57.76 | 63,594 | D | — | — | |
| 2 | Common | ReMed Common Stock | 2022-11-23 | A | A | 6,924 | $0.00 | 66,741 | D | — | — | |
| 3 | Common | ReMed Common Stock | 2022-11-22 | S | D | 3,777 | $229.50 | 59,817 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price. |
| 4 | Derivative | ResMed Common Stock Options | 2022-11-22 | M | D | 15,000 | $0.00 | 0 | D | $57.76 · 2017-11-16 to 2023-11-16 | 15,000 ResMed Common Stock |